Chemically induced self-assembly of enzyme nanorings

Methods Mol Biol. 2011:743:17-26. doi: 10.1007/978-1-61779-132-1_2.

Abstract

Continued exploration into the field of chemically induced dimerization (CID) has revealed a number of applications for its use in a broader context as a method of structural assembly (1-4). In particular, the use of CID technology to generate self-assembled (and selectively disassembled) protein toroids serves as a key advancement toward developing stable and controllable protein-based platforms. Such structures have broad application to the development of novel therapeutics, lab-on-a-chip technologies, and multi-enzyme assemblies (5, 6). This chapter describes a method of developing an enzymatically active protein nanostructure incorporating both a CID-based assembly region containing dihydrofolate reductase (DHFR) and an enzymatic region consisting of histidine triad nucleotide binding protein 1 (Hint1). Details of both the production and the characterization of this structure are provided.

MeSH terms

  • Binding Sites / drug effects
  • Chromatography, Gel
  • Cloning, Molecular
  • Escherichia coli
  • Gene Expression
  • Histidine / metabolism
  • Humans
  • Kinetics
  • Methotrexate / chemistry*
  • Methotrexate / pharmacology
  • Models, Molecular
  • Nanoconjugates / analysis
  • Nanoconjugates / chemistry
  • Nerve Tissue Proteins / chemistry
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / metabolism*
  • Protein Multimerization / drug effects*
  • Protein Structure, Tertiary
  • Recombinant Fusion Proteins / chemistry
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / metabolism*
  • Tetrahydrofolate Dehydrogenase / chemistry
  • Tetrahydrofolate Dehydrogenase / genetics
  • Tetrahydrofolate Dehydrogenase / metabolism*

Substances

  • HINT1 protein, human
  • Nanoconjugates
  • Nerve Tissue Proteins
  • Recombinant Fusion Proteins
  • Histidine
  • Tetrahydrofolate Dehydrogenase
  • Methotrexate